Latest Conference Articles

Growth in new biologic treatments for widespread cutaneous disease along with innovation in medications for rare conditions such as generalized pustular psoriasis have moved infusion therapy from a nice-to-know to a need-to-know point on dermatologists’ continuing learning curve. The National Infusion Center Association provides answers to commonly asked questions about biologics in an informative presentation at the end of this article.

At the 2022 National Infusion Center Association Annual Conference, Kelly Gordon, PharmD, answered why diagnosing GPP is so difficult and what to look for to optimize patient care.

Robert Dracker, MD, MHA, MBA, CPI discussed considerations and developmentally appropriate interventions to promote high quality, patient-centered pediatric infusion care in a presentation at the 2022 National Infusion Center Association Annual Conference.

At the SDPA 2022 Annual Summer Dermatology Conference, a session on both common and rare dermatological disorders.

Lindsey Savickas, RN, BSN, and COO at Infusion Associates, explains how infusion centers and dermatologists are going to work together more as medications become more advanced.

Brian Nyquist, MPH, the CEO of the National Infusion Center Association (NICA), talks on the engaging sessions happening this weekend at the NICA conference and its growing importance to the dermatology community.

The 2022 National Infusion Center Association Conference will begin with several sessions focused on advocacy, clinical, management, and operations topics.

The Society for Dermatology Physician Assistants (SDPA) begins its summer dermatology conference today, which will continue until Sunday, June 19, 2022, in Austin, Texas. Follow along for coverage.

Joshua Zeichner, MD, discusses how important it is to treat acne properly and gives a tip about moisturizers and topical retinoids.

Education, honesty, and communication skills are key for both patient and dermatologist when it comes to creating treatment regimens.

James Q. Del Rosso, DO, highlights different rosacea treatment options in his session at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Darrell S. Rigel, MD, MS, FAAD, answers the question of what is up coming in the world of dermatology in the way of precision medicine.

In a session for the 2022 Fall Clinical Dermatology Conference for PAs & NPs, held June 3 to 5, in Scottsdale, Arizona, James Q. Del Rosso, DO, delves into new knowledge on the characteristics of this challenging skin condition.

Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases (STDs) to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

In a video with Dermatology Times®, James Q. Del Rosso, DO, discusses his presentation “What’s News in the Medicine Chest” at the current 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Will drinking caffeinated coffee reduce skin cancer risk? Is gene expression profiling set to become mainstream testing for melanoma? See what Darrell S. Rigel, MD, MS, FAAD, has to say.

In a hard-hitting session from the 2022 Fall Clinical Dermatology Conference for PAs & NPs, April Armstrong, MD, MPH, dove into PAD technology and future innovations in psoriasis treatment.

A poster presented at the current 2022 Fall Clinical Dermatology Conference for PAs & NPs showed normalization of skin barrier function in patients with moderate to severe atopic dermatitis taking dupilumab, according to the investigators.

April Armstrong, MD, MPH, highlights her recommendations for improving patients’ outcomes, engagement, and satisfaction as part of a panel presentation at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Darrell S. Rigel highlights what to expect for the 2022 Fall Clinical Dermatology Conference for PAs & NPs happening June 3 to 5 in Scottsdale, Arizona.

Offering in-person and virtual formats, the 2022 Fall Clinical Dermatology Conference for PAs & NPs includes 3 days of informative sessions designed to help health care practitioners “unlock their value to their patients and their practice."

Data from one study showed younger women more likely to use sunscreen than older adults.

At the ACMS meeting, Chrysalyne D. Schmults, MD, MScE, highlighted molecular diagnostics for squamous cell carcinoma.

Overall, non-melanoma skin cancer (NMSC) visits (all pooled specialties/areas) have been plateauing. However , metropolitan but not rural areas saw an increase in visits where NMSC was the chief complaint. However, the percentage of NMSC in rural areas that is managed by dermatologists and dermatologic surgeons is also on the rise, according to a presentation given at the 2022 American College of Mohs Surgery Annual Meeting.

Single-stage periosteal flap technique to treat full-thickness eyelid defects is safe, effective, and aesthetically acceptable, according to a study presented at the 2022 American College of Mohs Surgery Annual Meeting on May 12, 2022.

At the current ACMS meeting, Kelsey E. Hirotsu, MD, discussed the bleeding complications seen in patients on ibrutinib for CLL.

A study presented at the current ACMS meeting highlights variables that could predict BCC, including: gender, immune status, and more.

Presenters highlight the possible solutions to communication between the scrubbed-in surgery team and outside help that could save time.